NCT00652951 - Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib | Biotech Hunter

Enrollment

780

Participants

Timeline

Start Date

April 1, 2008

Primary Completion Date

May 12, 2009

Study Completion Date

December 1, 2010

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL

GSK Biologicals´ Pneumococcal Conjugate Vaccine GSK1024850A (Synflorix™)

Intramuscular injection, 3 doses in the primary vaccination and 1 dose in the booster vaccination

BIOLOGICAL

Infanrix™ hexa.

Intramuscular injection, , 3 doses in the primary vaccination and 1 dose in the booster vaccination

BIOLOGICAL

Pediacel™

Intramuscular injection, , 3 doses in the primary vaccination and 1 dose in the booster vaccination

BIOLOGICAL

Prevenar™

Intramuscular injection, , 3 doses in the primary vaccination and 1 dose in the booster vaccination

Trial Locations (1)

GSK Investigational Site, Hoofddorp